Due to its unique waterless nature, it may feel 'oily' for a few seconds to some
If you have other obesity-related health conditions that would benefit from significant weight loss (sleep apnea, hypertension, joint problems), GLP-1 medications address multiple conditions simultaneously
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers
10.3233/JAD-161088 189 UllahN.HasnainS
We found that the receptor doesnt just signal at the cell surface, it moves inside the cell to form a specialised hub at ER contact sites
By the late 1980s, it was clear that therapeutically using GLP-1 would require either modifying the molecule to last longer or finding another way to keep levels high